Tagomics secures 6.7M euros to revolutionize disease diagnosis with multiomics
Longevity Technology - 21-Feb-2024Unlocking a new era of comprehensive disease insights and treatment strategies
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
CEO and Co-founder at Tagomics
Jack Kennefick is the Chief Executive Officer & Co-founder at Tagomics. His main focus is on harnessing the power of multiomics to advance disease understanding, detection and treatment.
Jack holds a Masters degree in Molecular Biotechnology and PhD in Epigenetics from University of Birmingham.
Visit website: https://tagomics.com/who-we-are/#JackKennefick
See alsoDetails last updated 01-Apr-2024
Unlocking a new era of comprehensive disease insights and treatment strategies